Status:
COMPLETED
Lumigan Versus Cosopt
Lead Sponsor:
Pharmaceutical Research Network
Conditions:
Open-Angle Glaucoma
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the intraocular pressure effect and safety of the dorzolamide/timolol fixed combination given twice daily versus bimatoprost given once every evening in patients with open-angle glaucoma in...
Eligibility Criteria
Inclusion
- adults with a diagnosis of bilateral open-angle glaucoma including: primary, pigment dispersion or exfoliation in both eyes
- on no therapy the intraocular pressure should be 22-29 mm Hg inclusive at the 8:00 AM measurement
- visual acuity should be 20/200 or better in each eye
Exclusion
- historical failure to respond to topical beta-blockers in a clinically meaningful manner
- any contraindication to study medications
- any anticipated change, or modification in the 6 weeks prior to Visit 1, in systemic hypertensive therapy during the trial
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00273455
Start Date
January 1 2006
End Date
May 1 2007
Last Update
November 19 2008
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Taustine Eye Center
Louisville, Kentucky, United States, 40217
2
Glaucoma Consultants & Center for Eye Research, PA
Mt. Pleasant, South Carolina, United States, 29464
3
Houston Eye Associates
Houston, Texas, United States, 77025